Showing results (371-380 of 1,393) with videos related to

Sort By:
Pageof 140
JCO Precision Oncology|January 12, 2023
Modeling Costs and Life-Years Gained by Population-Wide Next-Generation Sequencing or Single-Gene Testing in Nonsquamous Non-Small-Cell Lung Cancer in the United StatesChristopher A Lemmon, Jie Zhou, Brian Hobbs, et al.
JCO Precision Oncology|June 15, 2022
Selpercatinib-Induced Hypothyroidism Through Off-Target Inhibition of Type 2 Iodothyronine DeiodinaseLaura Boucai, Federico Salas-Lucia, Gnana P Krishnamoorthy, et al.
JCO Precision Oncology|June 22, 2022
Clinical and Genomic Characterization of Bladder Carcinomas With Glandular PhenotypeNima Almassi, Karissa Whiting, Antoun Toubaji, et al.
JCO Precision Oncology|June 23, 2022
Disparities in Biomarker Testing and Clinical Trial Enrollment Among Patients With Lung, Breast, or Colorectal Cancers in the United StatesDebora S Bruno, Lisa M Hess, Xiaohong Li, et al.
JCO Precision Oncology|July 7, 2022
Matched Molecular Profiling of Cell-Free DNA and Tumor Tissue in Patients With Advanced Clear Cell Renal Cell CarcinomaRitesh R Kotecha, Erika Gedvilaite, Ryan Ptashkin, et al.
JCO Precision Oncology|November 29, 2022
Germline Variants in DNA Damage Repair Genes and HOXB13 Among Black Patients With Early-Onset Prostate CancerMatthew R Trendowski, Christopher Sample, Tara Baird, et al.
JCO Precision Oncology|November 29, 2022
Proceedings From the ASCO/College of American Pathologists Immune Checkpoint Inhibitor Predictive Biomarker SummitDaniel F Hayes, Roy S Herbst, Jonathan L Myles, et al.
JCO Precision Oncology|May 25, 2019
Genomic Characterization of Prostatic Ductal Adenocarcinoma Identifies a High Prevalence of DNA Repair Gene MutationsMichael T Schweizer, Emmanuel S Antonarakis, Tarek A Bismar, et al.
JCO Precision Oncology|October 11, 2021
Clinical Utility of Plasma-Based Comprehensive Molecular Profiling in Advanced Non-Small-Cell Lung CancerRobert D Schouten, Daan C L Vessies, Linda J W Bosch, et al.
JCO Precision Oncology|April 18, 2024
Transcriptome-Based Prognostic and Predictive Biomarker Analysis of ENACT: A Randomized Controlled Trial of Enzalutamide in Men Undergoing Active SurveillanceAshley E Ross, Kenneth K Iwata, Dina Elsouda, et al.
Pageof 140